cemiplimab
E1997220
UNEXPLORED
Cemiplimab is a human monoclonal antibody immune checkpoint inhibitor used in cancer therapy, particularly for advanced cutaneous squamous cell carcinoma and other tumors.
All labels observed (1)
| Label | Occurrences |
|---|---|
| cemiplimab canonical | 1 |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.